The Cannigma

DECEMBER 12, 2022

Now, psychedelic research is booming. And while most psychedelics are currently illegal in the United States and around the world, researchers are exploring their use in medicine to treat conditions such as depression, PTSD, addiction, anxiety, OCD, migraines, end of life acceptance of mortality, and eating disorders. 19 20 21 22 23.

History 119

History Microdosing Research and Development Clinical Trials 119

Cannabis Law Report

AUGUST 10, 2021

We are delighted by today’s decision from the MHRA for this new indication, which represents a significant step forward for TSC patients in the UK, many of whom may benefit from this new treatment,” said Chris Tovey , Executive Vice President, Chief Operating Officer and Managing Director, Europe & International at Jazz Pharmaceuticals.

Pharmaceutical 98

Pharmaceutical Treatment Epilepsy Research and Development 98

LifeCannMD

MARCH 3, 2025

In Miami, Dr. Fernando Fandio-Sende researches innovative approaches to OCD treatment that have emerged, with medical marijuana integrative wellness strategies increasingly recognized as a potential therapeutic avenue worth exploring. For people dealing with OCD, this connection could be really important.

Research and Development 52

Research and Development Treatment Conditions Patients 52

WeedAdvisor

JANUARY 8, 2019

For decades, marijuana for cancer treatment seemed out of the question. The drug’s status as a controlled substance meant that research into its anti-tumour potential was sparse. While research into the topic is rare, it is not non-existent. The Endocannabinoid System in Cannabis Cancer Treatment.

Treatment 75

Treatment Research and Development Cannabinoids THC 75

Cannabis Info

MARCH 2, 2019

Marijuana as a treatment for epilepsy. Medical cannabis is showing great potential in the treatment of epilepsy. It is only in recent human history, that this mighty herb fell victim to human greed and was bound into the chains of prohibition. CONVENTIONAL TREATMENT. CANNABIS AS A POTENTIAL TREATMENT.

Epilepsy 69

Epilepsy Treatment Marijuana Research and Development 69

Cannabis Law Report

JULY 28, 2021

To date, the clinic network has seen over 75,000 unique patients and has conducted extensive research in cannabinoid therapy as it relates to sleeping disorders, opioid reduction and other topics. General Research: The Company has engaged General Research GmbH (“GR”) to increase its exposure to investors in Europe.

Clinical Trials 81

Clinical Trials Research and Development Treatment Therapy 81

The Cannigma

MARCH 17, 2021

While emerging research is showing that cannabis may be effective in managing the symptoms of depression and other mental health disorders, research into its use for PPD remains largely unexplored and unpublished about. The need for more research is especially true for women suffering from PPD. Here’s what we know.

Research and Development 141

Research and Development Treatment Sleep Cannabis 141

Veriheal

OCTOBER 13, 2020

Cannabis has been identified as an effective alternative treatment for some gastrointestinal disorders…but does that include IBD and IBS? . The exact causes of IBD are still unknown but risk factors such as age, race, family history, cigarette smoking, anti-inflammatory as well as environmental factors such as where the individual lives.

Digestion 124

Digestion Treatment Conditions Research and Development 124

MMJ Recs

FEBRUARY 10, 2024

This article explores the history of medical marijuana in Ohio, analyzes the changing attitudes and acceptance, and delves into the impact of stigma on its journey to legalization. Scientific research, patient testimonials, and a broader understanding of the plant’s medicinal properties have fundamentally altered public views.

Research and Development 105

Research and Development Marijuana History Legislation 105

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. As two emergent complementary medicines, many parallels exist between the medical cannabis industry and the currently developing psychedelic medicine industry.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

United Patients Group

SEPTEMBER 7, 2023

As the perception of medical marijuana evolves and an increasing number of individuals explore its therapeutic potential, it’s crucial to develop a comprehensive understanding of cannabis’ impact on bodily systems. One area of interest and ongoing research is the relationship between cannabis and the immune system.

Research and Development 111

Research and Development Conditions Cannabinoids Patients 111

Cannabis Law Report

AUGUST 22, 2021

The addition of methylated tryptamines with pending patent protection is focused on the potential improvement of treatments for mental health conditions including depression, anxiety and addiction, as well as other psychological and neurologic conditions. ” About PsyBio Therapeutics Corp.

Clinical Trials 98

Clinical Trials Research and Development Treatment Conditions 98

Greencamp

AUGUST 16, 2018

In this comprehensive guide, we are exploring the research on using cannabis for treating Amyotrophic lateral sclerosis (ALS)—a rare neuron disease that targets the motor neurons in the body. Brief history of ALS. Exploring the available research on ALS and cannabinoids. How to Get a Medical Marijuana Prescription in Canada.

Strains 94

Strains Cannabinoids Research and Development Indica 94

CannaMD

AUGUST 26, 2020

Current Cocaine Treatments. As researchers point out: There is no gold standard pharmacological treatment for dependence on cocaine. Although several drugs have been investigated, there is no strong or consistent evidence indicating any of these drugs for the treatment of cocaine use disorder.

Therapy 98

Therapy CBD Research and Development Treatment 98

Veriheal

JULY 9, 2021

According to Yale University Professor of Psychiatry Cyril Desouza, where the study was carried out, approximately three out of 10 people are developing a cannabis use disorder. For the past 25 years, Desouza has been investigating the world of cannabinoid treatment options. His most recent bout of research is already two years deep.

Treatment 52

Treatment Research and Development Consumption Sleep 52

PrestoDoctor

SEPTEMBER 26, 2023

Research suggests that cannabis can affect various aspects of mental health , including mood, cognition, and behavior. It’s important to note that not everyone who uses cannabis will develop mental health issues. Research suggests that there is indeed a link between cannabis use and mental health issues.

Research and Development 105

Research and Development Chronic Pain Sleep Conditions 105

MMJ Recs

JULY 11, 2024

Medical marijuana is a potential treatment for insomnia, and it offers an alternative to traditional pharmaceuticals. Chronic insomnia often requires a more comprehensive treatment approach. It has shown effectiveness in helping individuals develop better sleep habits and manage insomnia symptoms without relying on medication.

Sleep 111

Sleep Treatment Research and Development Therapy 111

Cannabis Law Report

JUNE 21, 2021

Pharmaceutical companies use artificial intelligence (AI) to sort through reams of scientific data to find potentially effective active ingredients to be developed into approved drugs. Over the prior three years or so, 41,260 RYAH-connected patients reported medical cannabis use for the treatment of pain. RYAH Group Inc. The Upshot.

Data 105

Data Clinical Trials Research and Development Indica 105

Greencamp

JANUARY 5, 2019

Both environmental and genetic factors play an important role in developing this mental disorder, and these different factors are sometimes quite difficult to separate. There are many onset symptoms and other indications to warn us that someone has started developing schizophrenia. Research on cannabis and schizophrenia.

Research and Development 96

Research and Development Marijuana History Patients 96

Veriheal

SEPTEMBER 27, 2021

Medical cannabis has been legal in the nation for almost three years—so why are MS patients struggling to access the treatment? A survey conducted by researchers in 2017 revealed that more than 40% of MS patients use medical cannabis. . 1, MS Society UK posted on Twitter , “Getting the treatment you need shouldn’t be a game of chance.

Treatment 98

Treatment Patients Access Research and Development 98

United Patients Group

APRIL 18, 2023

However, there are still many myths about cannabis that persist despite being debunked by medical professionals and researchers alike. While it can be used to treat many different conditions and symptoms, it’s important to note that not everyone will respond positively to medical cannabis treatment. Myth: Cannabis is just a drug.

Research and Development 116

Research and Development Indica Treatment Conditions 116

MMJ Recs

MAY 25, 2024

Medical marijuana has been a hot topic over the years – from the stigma it surrounds the cannabis industry to its legalization in US states and its research and use for treating various ailments. However, further studies are needed to fully understand the mechanisms and potential of ECS modulation in mental health treatment.

Patients 105

Patients Marijuana Cannabinoids Chronic Pain 105

Cannabis Law Report

SEPTEMBER 22, 2021

This change would mean it would be easier to run trials on its use in mental health treatments. The Prime Minister had already approved the rescheduling of psilocybin for exploring its potential as a treatment for depression, which he informed Mr Blunt in a meeting in May.

Research and Development 52

Research and Development Clinical Trials Treatment History 52

PrestoDoctor

SEPTEMBER 15, 2023

While there are a variety of treatments available, many individuals do not find relief with traditional medications or therapies. However, recent research suggests that cannabis may be a promising option for those seeking relief from OCD symptoms. It is a serious medical condition that requires appropriate treatment and support.

Research and Development 105

Research and Development Therapy Treatment Strains 105

MMJ Recs

FEBRUARY 21, 2024

Through an examination of existing research and anecdotal evidence, we aim to provide a closer look at the potential effects of medical marijuana on women’s health. Research suggests that cannabinoids may have anti-inflammatory and analgesic effects, potentially aiding in symptom relief.

Chronic Pain 105

Chronic Pain Marijuana Research and Development Cannabinoids 105

MMJ Recs

MAY 15, 2024

Traditional treatment modalities, ranging from psychotherapy to pharmacotherapy, have long served as the cornerstone of anxiety management, offering pathways to relief for those burdened by its relentless grip. However, with the proper treatment, individuals can manage, recover, and reclaim control over their mental health and well-being.

Marijuana 105

Marijuana Therapy Treatment Sleep 105

Veriheal

AUGUST 26, 2021

Further research led them to discover that the key to an effective prophylactic is the combination of the two hormones. The substance was first synthesized for the treatment of tuberculosis but they found that the patients were exhibiting euphoric and hyperactive behavior. Iproniazid – The First MOAI Antidepressant.

Research and Development 98

Research and Development Clinical Trials Medicine Treatment 98

Veriheal

AUGUST 31, 2020

We are humbled to introduce you to them and their exceptional ideas, ranging from community grassroots mental health efforts designed to empower historically vulnerable communities of color, to research plans for identifying strain specific genetics. Veriheal’s Innovation in Cannabis Scholarship 2020 Winners . Nishtha Tripathi.

Research and Development 119

Research and Development Education Agriculture Patients 119

Cannabis Law Report

DECEMBER 9, 2021

MindMed presented FDA with a working Indications for Use statement (IFU), and a development roadmap. FDA provided key feedback regarding the draft IFU and the research methods that will lay the foundation for regulatory submissions. ” About MindMed.

Research and Development 52

Research and Development Clinical Trials Therapy Medicine 52

Cannabis Law Report

JUNE 19, 2022

The Center for Psychedelic Drug Research and Education (CPDRE) was approved by the Ohio State College of Social Work faculty in January, and its director, Assistant Professor of Social Work Alan Davis , officially took the helm in March. Initial goals of the center are focused on research and educational initiatives.

Education 52

Education Research and Development Therapy Clinical Trials 52

The Cannigma

JANUARY 16, 2023

1 Muscimol is a well-researched, natural compound and has been studied as a potential treatment for drug-resistant epilepsy, its potential effects on neurological disorders, and its pain-relieving abilities. Muscimol was the molecule used by scientists to develop numerous new pharmaceutical drugs aimed at targeting the GABA system.

Research and Development 127

Research and Development History Treatment Retail 127

Cannabis Law Report

JULY 7, 2021

is a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments. It is working to provide the critical infrastructure needed to develop and deliver breakthrough mental health treatments. KetamineOne Capital Limited (formerly Myconic Capital Corp.)

Research and Development 98

Research and Development Treatment Therapy Banking 98

CannaMD

JANUARY 30, 2021

It’s been 50 years since researchers first identified marijuana as a potential therapeutic agent for the treatment of glaucoma. In the state of Florida and most other states that have legalized medical marijuana, glaucoma remains a qualifying condition for cannabis-based treatments. MARIJUANA LOWERS IOP.

Blood Pressure 83

Blood Pressure Marijuana Research and Development Therapy 83

PrestoDoctor

SEPTEMBER 13, 2023

While there are many traditional treatments available, some mothers are turning to CBD oil as a natural alternative to help alleviate their symptoms. While research on CBD and postpartum depression is still in its early stages, some studies suggest that CBD may help alleviate symptoms of depression and anxiety.

CBD 105

CBD Research and Development Sleep Treatment 105

Veriheal

FEBRUARY 14, 2024

The vote passed 7-0 after a group of senators, first responders, and military members held a press conference regarding the benefits and potential of psilocybin, also known as magic mushrooms , for mental health treatment. This will also include licensing for centers that are working on psilocybin and psychedelic research.

Therapy 64

Therapy Legalization Research and Development Treatment 64

Veriheal

APRIL 18, 2022

According to the 2022 study published in the journal Drug and Alcohol Dependence, researchers found that smoking cannabis accelerates the biological aging process. The researchers decided to make use of a tool known as “ epigenetic clocks” in order to understand whether smoking cannabis accelerates or decreases the aging process.

Research and Development 98

Research and Development Clinical Trials Conditions Cannabis 98

PrestoDoctor

OCTOBER 13, 2023

Initially developed in the 1980s, Marinol was primarily used to alleviate symptoms associated with chemotherapy-induced nausea and vomiting. It was later approved for the treatment of anorexia in patients with HIV/AIDS who experience severe weight loss. However, unlike marijuana, Marinol is a FDA-approved pharmaceutical drug.

THC 98

THC Chronic Pain Treatment Conditions 98